Results 41 to 50 of about 10,600 (216)

Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus

Expert Review of Vaccines
Introduction Varicella-zoster virus (VZV) is a highly contagious virus that manifests as varicella (chickenpox) as primary infection and reactivates as herpes zoster (HZ, shingles), with the potential for severe complications.
Giacomo Casabona, Paolo Bonanni, Giovanni Gabutti, Volker Vetter, Maurine Duchenne, Raunak Parikh   +5 more
doaj   +1 more source

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium [PDF]

, 2019
Funding text The authors are grateful for the vital contributions of the participating study volunteers, clinicians, nurses, and laboratory technicians at the Surrey study site.
Bodinham, C., Bottazzi, B., DelGiudice, G., Denoel, P., Greenwood, A., Jonsdottir, I., Kaufmann, S., Kester, K., Leroux-Roels, G., Lewis, D., Linley, C., Maertzdorf, J., Mantovani, A., Mollenkopf, H., Pizzoferro, K., van den Berg, R., Weiner, J.   +16 more
core   +1 more source

Prolonged Neurological and Musculoskeletal Symptoms Following Shingrix Vaccination

Reports
Background and Clinical Significance: The recombinant zoster vaccine (Shingrix) helps prevent shingles and its complications in adults 50 and older. While minor side effects are common, severe adverse reactions are thought to be rare, and long-term side ...
Sabrina Hollar, Amna Khalid, Benjamin D. Brooks, Michael Wons   +3 more
doaj   +1 more source

Recruitment of naive CD4+ T cells by the recombinant zoster vaccine correlates with persistent immunity

The Journal of Clinical Investigation, 2023
Herpes zoster (HZ) is a substantial problem for people with decreased cell-mediated immunity, including older adults. The first vaccine approved for HZ prevention, the zoster vaccine live (ZVL), which provided limited and short-lived protection, has been
Kerry J. Laing, Emily S. Ford, Michael J. Johnson, Myron J. Levin, David M. Koelle, Adriana Weinberg   +5 more
doaj   +1 more source

Molecular Aspects of Varicella-Zoster Virus Latency [PDF]

, 2018
Primary varicella-zoster virus (VZV) infection causes varicella (chickenpox) and the establishment of a lifelong latent infection in ganglionic neurons. VZV reactivates in about one-third of infected individuals to cause herpes zoster, often accompanied ...
Depledge, D.P. (Daniel P.), Ouwendijk, W.J.D. (Werner), Sadaoka, T. (Tomohiko)   +2 more
core   +4 more sources

Organizing Pneumonia Following Recombinant Zoster Vaccination: A Rare Adverse Reaction

Cureus, 2022
We describe a case of a severe but rare adverse reaction to recombinant varicella-zoster virus (VZV) vaccination: a 67-year-old female admitted with gradual onset of shortness of breath, hypoxia, and fever following VZV vaccination. The clinical picture and radiologic presentation mimicked COVID-19 pneumonia.
Khawaja, Imran, Al-Ourani, Mohammed
openaire   +2 more sources

Current status of immunisation for herpes zoster

Human Vaccines & Immunotherapeutics
Herpes zoster (HZ) is increasingly common in the aging and is experienced by approximately one in three people in their lifetime. It is also relatively common in immune-compromised people.
Anthony Lawrence Cunningham, Kerrie Jane Sandgren, Janette Taylor   +2 more
doaj   +1 more source

Envelope Determinants of Equine Lentiviral Vaccine Protection [PDF]

, 2013
Lentiviral envelope (Env) antigenic variation and associated immune evasion present major obstacles to vaccine development. The concept that Env is a critical determinant for vaccine efficacy is well accepted, however defined correlates of protection ...
A Kumar, A Kumar, AJ Mcmichael, AT Das, B Berkhout, BA Sponseller, BF Haynes, C Leroux, C Leroux, C Leroux, CH Grund, Charles J. Issel, CJ Issel, Corin Ezzelarab, D Shental-Bechor, David Horohov, DC Montefiori, DL Lichtenstein, DL Lichtenstein, EW Uhl, F Li, F Li, F Li, J Mills, JB Whitney, JK Craigo, JK Craigo, JK Craigo, JK Craigo, JK Craigo, JK Craigo, JK Craigo, JK Craigo, JM Ball, Jodi K. Craigo, K Abel, KA Hussain, L Coggins, L Howe, L Howe, Liu Chong, M Busch, MJ Papandreou, ML Raabe, MR Raabe, MR Reynolds, N Almond, PM Rwambo, PM Rwambo, R Hofmann-Lehmann, RC Montelaro, RF Cook, RM Ruprecht, Ronald C. Montelaro, RP Johnson, RP Johnson, RP Johnson, RR Amara, S Hambleton, SA Hammond, SA Hammond, SA Hammond, Sheila J. Cook, SL Payne, SM Blower, SM Harrold, SZ Wang, TL Tagmyer, TL Tagmyer, TW Baba, TW Baba, WC Koff, WM Bogers, Y Kono, YH Zheng, YH Zheng, Zhiping Ye   +76 more
core   +3 more sources

Awareness and acceptability of herpes zoster vaccination in people living with HIV

Preventive Medicine Reports
Objective: The recombinant herpes zoster vaccine is recommended for aging populations to prevent herpes zoster. We aimed to assess awareness of herpes zoster and acceptance of the herpes zoster vaccine acceptance among people living with HIV (PLWH ...
Christian Motet, Agnès Libois, Charlotte Martin, Nicolas Dauby   +3 more
doaj   +1 more source

Vaccines of the future [PDF]

, 2011
Meteorological observations at Bayelva Station in 2016 (level ...
Boike, Julia, Bornemann, Niko, Burke, Eleanor J, Chadburn, Sarah, Gouttevin, Isabelle, Hauber, Ernst, Ippisch, Olaf, Juszak, Inge, Lange, Stephan, Overduin, Pier Paul, Roth, Kurt, Stern, Lielle, Westermann, Sebastian   +12 more
core   +1 more source